These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37587888)

  • 21. Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of Alzheimer's disease.
    Wang CF; Song CY; Wang X; Huang LY; Ding M; Yang H; Wang P; Xu LL; Xie ZH; Bi JZ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3542-3550. PubMed ID: 31081111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A map of the PPARα transcription regulatory network for primary human hepatocytes.
    McMullen PD; Bhattacharya S; Woods CG; Sun B; Yarborough K; Ross SM; Miller ME; McBride MT; LeCluyse EL; Clewell RA; Andersen ME
    Chem Biol Interact; 2014 Feb; 209():14-24. PubMed ID: 24269660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.
    Reddy PH; Manczak M; Kandimalla R
    Hum Mol Genet; 2017 Apr; 26(8):1483-1496. PubMed ID: 28186562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.
    Reddy AP; Sawant N; Morton H; Kshirsagar S; Bunquin LE; Yin X; Reddy PH
    Hum Mol Genet; 2021 May; 30(9):789-810. PubMed ID: 33791799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.
    Reddy AP; Yin X; Sawant N; Reddy PH
    Hum Mol Genet; 2021 May; 30(10):847-864. PubMed ID: 33615359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model.
    Chandra S; Roy A; Jana M; Pahan K
    Neurobiol Dis; 2019 Apr; 124():379-395. PubMed ID: 30578827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of PGC-1α-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease.
    Singulani MP; Pereira CPM; Ferreira AFF; Garcia PC; Ferrari GD; Alberici LC; Britto LR
    Exp Gerontol; 2020 May; 133():110882. PubMed ID: 32084533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease.
    Vijayan M; Bose C; Reddy PH
    Mitochondrion; 2021 Jul; 59():17-29. PubMed ID: 33839321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
    Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP
    Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
    Robinson A; Grösgen S; Mett J; Zimmer VC; Haupenthal VJ; Hundsdörfer B; Stahlmann CP; Slobodskoy Y; Müller UC; Hartmann T; Stein R; Grimm MO
    Aging Cell; 2014 Apr; 13(2):263-72. PubMed ID: 24304563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway.
    Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
    Int J Dev Neurosci; 2014 Nov; 38():223-31. PubMed ID: 25447788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treadmill workout activates PPARα in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer's disease.
    Rangasamy SB; Jana M; Dasarathi S; Kundu M; Pahan K
    Brain Behav Immun; 2023 Mar; 109():204-218. PubMed ID: 36682514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.
    Nakaya K; Tohyama J; Naik SU; Tanigawa H; MacPhee C; Billheimer JT; Rader DJ
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1276-82. PubMed ID: 21441141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?
    Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.
    Duncan JG; Fong JL; Medeiros DM; Finck BN; Kelly DP
    Circulation; 2007 Feb; 115(7):909-17. PubMed ID: 17261654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
    Kersten S; Stienstra R
    Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?
    Zolezzi JM; Silva-Alvarez C; Ordenes D; Godoy JA; Carvajal FJ; Santos MJ; Inestrosa NC
    PLoS One; 2013; 8(5):e64019. PubMed ID: 23675519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes.
    Goto T; Lee JY; Teraminami A; Kim YI; Hirai S; Uemura T; Inoue H; Takahashi N; Kawada T
    J Lipid Res; 2011 May; 52(5):873-84. PubMed ID: 21324916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.